0001551986-18-000029.txt : 20180910 0001551986-18-000029.hdr.sgml : 20180910 20180910174920 ACCESSION NUMBER: 0001551986-18-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180907 FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laumas Sandeep CENTRAL INDEX KEY: 0001721664 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37797 FILM NUMBER: 181063564 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT RD, SUITE 200 CITY: RALEIGH STATE: NC ZIP: 27615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 4 1 wf-form4_153661614405437.xml FORM 4 X0306 4 2018-09-07 0 0001551986 INNOVATE BIOPHARMACEUTICALS, INC. INNT 0001721664 Laumas Sandeep C/O INNOVATE BIOPHARMACEUTICALS, INC., 8480 HONEYCUTT ROAD, SUITE 120 RALEIGH NC 27615 1 1 0 0 Executive Chairman Common stock 2018-09-07 4 P 0 500 6.10 A 2000 D Common stock 758373 I By Bearing Circle Capital LLC Due to an administrative error, the holdings reported on Dr. Laumas's prior Form 4 filing were understated by 750 shares. This balance now reflects the correct amount of Dr. Laumas's direct holdings. These shares are held by Bearing Circle Capital LLC. Dr. Laumas is affiliated with Bearing Circle Capital LLC and has voting and investment power over the shares held by Bearing Circle Capital LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose. /s/ Kendyle Woodard, as Attorney-in-Fact 2018-09-10